Podcasts about drug abuse nida

What makes addiction treatment truly effective? Behavioral scientist Charles Neighbors, MBA, PhD, shares groundbreaking research on the importance of therapeutic relationships, harm reduction, and human connection—love!—in treating substance use disorders. Dr. Neighbors is an Associate Professor in the Departments of Population Health, and Psychiatry at NYU Grossman School of Medicine.

In this deeply moving episode, Dwayne sits down with Emily Williams to explore her remarkable story. Once a rising star in the equestrian world, Emily's life took a devastating turn following the loss of her mother. Battling grief, addiction, and an abusive relationship, she faced homelessness and despair before making a courageous decision to reclaim her life. This candid conversation delves into the emotional depths of her struggles, the impact of shame and guilt, and the strength it takes to rebuild. Listeners will gain insight into addiction, loss, resilience, and the importance of self-awareness in overcoming personal battles. Emily's story is a powerful testament to the human spirit's ability to rise, fall, and rise again.Timestamps:[00:00:00] – Introduction to the episode and guest, Emily Williams[00:01:30] –Dwayne shares how he discovered Emily's story[00:03:00] – The connection between business, relationships, and personal struggles[00:06:00] – Emily's early success: A prodigy in the equestrian world[00:08:00] – The loss of her mother and the emotional impact[00:10:00] – The beginning of addiction: Partying, Adderall, and grief-driven rebellion[00:14:00] – The transition from discipline to self-destruction[00:17:00] – Losing responsibility and how it accelerates addiction[00:22:00] – Dropping out of school and falling into the party lifestyle[00:25:00] – Shame, guilt, and feeling undeserving of redemption[00:32:00] – A toxic relationship: Drug use, manipulation, and emotional control[00:39:00] – The descent into meth use and how it rewires the brain[00:42:00] – The breaking point: Walking away from addiction and an abusive relationship[00:47:00] – Narcissism, control, and the power of saying ‘no'[00:48:30] – Teaser for next week's continuation of Emily's journeyNotable Quotes:"Sometimes the most challenging situations are what we learn the most from." – Emily Williams"I felt so small… I had to lie to myself to be okay with who I was, but I wasn't okay." – Emily WilliamsResources & Mentions:Books: The Coddling of the American Mind – Jonathan Haidt & Greg LukianoffMental Health & Addiction Support:National Institute on Drug Abuse (NIDA): www.drugabuse.govSAMHSA's National Helpline: www.samhsa.gov or call 1-800-662-HELPNarcotics Anonymous (NA): www.na.orgConnect with Dwayne KerriganLinked In: https://www.linkedin.com/in/dwayne-kerrigan-998113281/Facebook: https://www.facebook.com/businessofdoingbusinessdkInstagram: https://www.instagram.com/thebusinessofdoingbusinessdk/Website: www.dwaynekerrigan.comDisclaimer The views, information, or opinions expressed by guests during The Business of Doing...

Matt Bair and Ryan Hedrick are back for another deep dive into the realities of addiction and recovery. Today, we’re tackling Suboxone—one of the most debated drugs in the recovery world. Some say it’s a lifesaver, giving people a real shot at staying off opioids. Others argue it’s just swapping one addiction for another, with its own set of side effects and risks. So what’s the truth? Does Suboxone truly help, or is it the disease in disguise? We’ll break it all down—the claims that Suboxone gets you high, the medical community’s stance, and the real-life impact it has on people in recovery. Plus, we’ll hear from Brandon Dreiman, a former Indianapolis firefighter and recovering addict, who brings his own experience to the table. This is a conversation you don’t want to miss. Let’s get into it. Medical & Addiction Recovery Resources SAMHSA (Substance Abuse and Mental Health Services Administration) – www.samhsa.gov Information on medication-assisted treatment (MAT), including Suboxone, plus a treatment locator. National Institute on Drug Abuse (NIDA) – www.drugabuse.gov Research-based information on Suboxone, opioid addiction, and recovery options. Mayo Clinic – www.mayoclinic.org Medical perspective on Suboxone, including potential side effects and how it works. Additional Resources Al-Anon – Al-Anon.org AA Meetings – aa.rgroup.org/meetings NA Meetings – virtual-na.org Suicide Prevention Hotline – (800) 273-8255 Follow & Support the Show Please find us on X and Instagram: @sobriety_podListen on Spotify, Apple Podcasts, or wherever you get your podcasts.If you like what you hear, please like, subscribe, and leave a rating!See omnystudio.com/listener for privacy information.

Addiction is a pervasive issue affecting millions of people worldwide. In the United States alone, over 20 million adults suffer from substance use disorders, with relapse rates ranging between 40% to 60%, according to the National Institute on Drug Abuse (NIDA). These statistics underscore the immense challenge of overcoming addiction, particularly when conventional treatment methods often fall short. As bleak as these numbers are, there is a growing body of evidence suggesting that innovative approaches, such as plant-based nutrition, can play a critical role in recovery. Adam Sud's Transformational Journey One person who knows a lot about addiction is Adam Sud, the founder and CEO of Plant-Based for Positive Change. Adam has emerged as a leading advocate at the powerful intersection of plant-based nutrition, mental health, and addiction recovery. His journey is one of profound transformation, moving from a life marred by morbid obesity, addiction, and chronic diseases to becoming a beacon of hope and inspiration for those facing similar battles. Early Life Struggles and the Roots of Addiction Adam shares his experiences growing up in Texas, where he lived in a loving household with supportive parents. However, around the age of 12, Adam's life took a turn when his father became hypercritical of his and his twin brother's appearance, particularly their weight. This scrutiny triggered feelings of inadequacy and anxiety, which Adam tried to suppress through rebellious behavior. Diagnosed with ADHD and prescribed Ritalin, Adam recalls how this began a downward spiral into substance abuse, which he initially used as a means of coping with his insecurities. The Dark Path of Addiction Adam's story of addiction is harrowing. What started as prescribed medication for ADHD evolved into a dependency on drugs like Adderall, which provided him with a temporary sense of confidence and acceptance. This substance abuse masked his deeper emotional pain but also led him into a life of criminal activity, severe obesity, and isolation. By the age of 30, Adam had hit rock bottom, weighing 350 pounds and on the brink of homelessness, with his life deteriorating physically, emotionally, and spiritually. Full episode show notes: www.HealthScience.org/099-Adam-Sud 

The Wednesday Wrap August 21, 2024 • Rancho Palos Verdes is sliding into the Ocean. Elon to the rescue? • Ozempic, Wegovy, and other GLP-1 agonists show promising healthcare signs outside of weight loss. Link to episode on YouTube: https://youtube.com/live/WDUw6DJqhdI Check out Collier Landry's links below! ➡️ Wanna say thanks for a great episode? https://www.buymeacoffee.com/collierlandry ➡️ Patreon: https://www.patreon.com/collierlandry ➡️ Check out my Merch Store: https://www.collierlandry.com/store ➡️ Amazon Affiliate Link: https://www.amazon.com/shop/collierlandry Additional Episode notes: Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse. Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders and that GLP-1 receptor agonists show potential for treating people with alcohol use disorder (AUD). GLP-1 is a gut hormone that stimulates insulin secretion after eating. This promotes a feeling of fullness, helps regulate blood sugar, and reduces hunger cravings. Semaglutide and other GLP-1 agonists—medications that bind to GLP-1 receptors and mimic their effects—are currently used as treatments for diabetes and obesity. “Parts of the brain that drive eating behaviors overlap extensively with the drive to use alcohol or other substances,” explained Lorenzo Leggio, M.D., Ph.D., and Leandro Vendruscolo, Pharm.D., Ph.D., two of the study's senior authors. They added that there is also an overlap between the brain mechanisms that regulate overeating and those that contribute to the development and maintenance of substance use disorders, including AUD. Rancho Palos Verdes is a coastal city in south Los Angeles County, California. It sits atop the bluffs of the Palos Verdes Peninsula, neighboring three other cities in the Palos Verdes Hills: Palos Verdes Estates, Rolling Hills, and Rolling Hills Estates. Rancho Palos Verdes is known for its extensive nature preserves, hiking trails, school district, and high property values. • Sources used in this video may include public news sites, interviews, court documents, dedicated Facebook groups, and news channel segments. When quoting others, their statements are considered alleged until confirmed. It's important to note that my videos reflect my independent opinion, and I encourage you to do your own research. • Disclaimer: All defendants are presumed innocent until proven guilty in a court of law. The views expressed in this video are personal and may not represent the official position of any agency, organization, employer, or company. The assumptions made are solely the creator's own. These views are subject to change and should not be considered permanent. I do not guarantee the accuracy, completeness, suitability, or validity of the information in this video, and I am not liable for any errors, omissions, or damages resulting from its use. All information is provided as-is. It is your responsibility to verify the facts Learn more about your ad choices. Visit megaphone.fm/adchoices

Tonix Pharmaceuticals CEO Dr Seth Lederman tells Proactive's Stephen Gunnion the first patient has been enrolled in the Phase 2 CATALYST study involving TNX-1300, a novel therapy aimed at reversing the effects of cocaine intoxication. Lederman highlighted that this study, supported by the National Institute on Drug Abuse (NIDA), is a significant step forward in addressing the urgent issue of cocaine-related emergencies, which currently lack effective direct treatments. Lederman explained that TNX-1300 works by breaking down cocaine in the bloodstream, rendering it inactive and mitigating its dangerous effects. He also discussed the previous Phase 2A study where TNX-1300 showed compelling results in reversing cocaine's impact in a controlled laboratory setting. The Phase 2B study, according to Lederman, could yield results as soon as 2025, with potential pivotal implications for the treatment's future. Lederman also touched on the broader issue of cocaine intoxication in the US, noting that it often involves mixed drugs, such as cocaine combined with fentanyl, which complicates treatment and increases risks. The interview concluded with Lederman expressing optimism about the study's progress and its potential to fill a critical gap in emergency care. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #TonixPharmaceuticals #CocaineAddiction #TNX1300 #ClinicalTrial #DrugAbuse #SethLederman #FDAApproval #PharmaNews #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Q: How important is AA?A: Alcoholics Anonymous is the world's largest support group with 115,000 chapters worldwide and an estimated membership of over two million. Moreover, it is endorsed by the National Institute of Drug Abuse (NIDA) as an accepted evidence-based behavioural therapy. It carries much weight among many practitioners and treatment centres and is often recommended by therapists to help alcoholics take the next step in their recovery following front-line treatment.AA is the pioneer of 12-step programs all over the world. From it stem over 30 other 12-step programs, including Al-Anon, a support group for families, Narcotics Anonymous, Debtors Anonymous, Cocaine Anonymous, Gamblers Anonymous and 26 other programs dedicated to helping people overcome addictive disorders of one kind or another.

The 5th anniversary of Sci Guys means it's high time we spoke about marijuana. Literally… It's high time. Check out Noah's music: https://tr.ee/f9DikNPhdQ Massive thanks to Evan for vision mixing and keeping us relatively sane: https://youtube.com/evan You can WATCH the podcast over on our YouTube channel Help keep the show running by supporting us on Patreon! If you'd like to see more of us, follow our socials! sciguys.co.uk TikTok Twitter Instagram Facebook If you spot any points that need correcting, head to sciguys.co.uk/corrections Follow the Sci Guys @notcorry / @lukecutforth References & Further Reading Cannabis Background & Basics Cannabis | WHO https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis Marijuana | History, Effects, THC, & Legality | Britannica https://www.britannica.com/science/marijuana Hashish | Cannabis, THC, Intoxication | Britannica https://www.britannica.com/science/hashish Cannabis (Marijuana) DrugFacts | National Institute on Drug Abuse (NIDA) https://nida.nih.gov/publications/drugfacts/cannabis-marijuana What We Know About Marijuana https://www.cdc.gov/marijuana/what-we-know.html The Name of Cannabis: A Short Guide for Nonbotanists - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531363/ Hemp | Description, Products, Seeds, Fiber, & Uses | Britannica https://www.britannica.com/plant/hemp Marijuana and the Brain - How Marijuana Works | HowStuffWorks https://science.howstuffworks.com/marijuana3.htm Legality of cannabis - Wikipedia https://en.wikipedia.org/wiki/Legality_of_cannabis History of Cannabis History of cannabis and the endocannabinoid system - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605027/ On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica), Their Effects on the Animal System in Health, and Their Utility in the Treatment of Tetanus and Other Convulsive Diseases https://pubmed.ncbi.nlm.nih.gov/30161735/ Oldest evidence of marijuana use discovered in 2500-year-old cemetery in peaks of western China | Science https://www.science.org/content/article/oldest-evidence-marijuana-use-discovered-2500-year-old-cemetery-peaks-western-china Effects of Cannabis Use Adverse Health Effects of Marijuana Use - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827335/ Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/35142225/ Edible marijuana products and potential risks for pediatric populations https://pubmed.ncbi.nlm.nih.gov/35634702/ The Scientific History of Cannabinoids | Science| Smithsonian Magazine https://www.smithsonianmag.com/science-nature/the-scientific-history-of-cannabinoids-180981561/ Health Effects | Marijuana | CDC https://www.cdc.gov/marijuana/health-effects/index.html How does marijuana affect the brain? Psychological researchers examine impact on different age groups over time https://www.apa.org/monitor/2023/06/marijuana-effects-brain Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020) - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716494 https://www.cancer.org/cancer/managing-cancer/treatment-types/complementary-and-integrative-medicine/marijuana-and-cancer.html https://www.dea.gov/drug-information/drug-scheduling

Dr. Lynn Webster is a Senior Fellow at the Center for U.S. Policy; Associate Editor, Special Populations Section, Pain Medicine; Chief Medical Officer for PainScript; Author of the award-winning book, The Painful Truth Documentary; and Co-Producer of It Hurts Until You Die. Dr. Webster is the principal investigator for the National Institute on Drug Abuse (NIDA) award 5RC2DA028984-02, which is issued under the American Recovery and Reinvestment Act of 2009. Webster is board certified in pain medicine, addiction medicine, and anesthesiology. He is also a senior editor of Pain Medicine and a peer reviewer for several professional journals. The Opioid Risk Tool he developed can be found at the following link: https://nida.nih.gov/sites/default/files/opioidrisktool.pdf #DEA #pain #addiction #health #policy #patient #care #research

Dr. Itai Danovitch, MD, MBA is a Professor and the Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. He earned his bachelor's degree from UC Berkeley and his medical doctorate from the UCLA School of Medicine. He completed psychiatry residency at Columbia University, an addiction psychiatry fellowship at Cedars-Sinai Medical Center and a Master of Business Administration at the UCLA Anderson School of Management. Dr. Danovitch's clinical practice and research is focused on the treatment of substance use disorders and the integration of medical and mental health services. His current research is funded by the National Center for Advancing Translational Sciences (NCATS), the National Institute on Drug Abuse (NIDA), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). He is the author of over 80 articles and book chapters and co-editor of two books on substance use disorders. Dr. Danovitch is a Distinguished Fellow of the American Society of Addiction Medicine, a Distinguished Fellow of the American Psychiatric Association and past president of the California Society of Addiction Medicine. He also serves as a Governor-appointed state Commissioner on the California Mental Health Services Commission. We talked about Nature vs. Nurture, the possible causes of ADHD, stimulant meds, the stunning similarities between ADHD and Addiction and what parents can do in the case of a diagnosis.

The National Cannabis Roundtable Discusses Historic Recommendation to Reschedule CannabisThe team from the National Cannabis Roundtable (NCR) joins the Karson Humiston to discuss the recent historic recommendation to reschedule cannabis from Schedule 1 to Schedule 3. The episode begins with an overview of the background and context of the recommendation, including the previous speculation about the HHS recommendation and the release of hundreds of pages of documents confirming the recommendation.The NCR team, consisting of Saphira Galoob, Erin Moffet, and David Mangone, provides insights into the significance of the recommendation and its potential impact on the cannabis industry. They explain that the recommendation is a major milestone as it marks the first time a government entity has officially confirmed the need to move cannabis to Schedule 3. They emphasize that this recommendation aligns with the existing state programs and the growing acceptance of cannabis as a medical treatment.The discussion delves into the process of rescheduling cannabis, highlighting the eight-factor analysis conducted by the Health and Human Services (HHS) and the role of the DEA in implementing the recommendation. The team addresses concerns about potential negative reactions from the DEA and the impact on DEA funding. They explain that while there may be some opposition, the robust scientific analysis and the support from other federal agencies, such as the National Institute of Drug Abuse (NIDA), provide a strong foundation for the recommendation.The team also addresses questions about the timing of the DEA's response and the potential enforcement of the illicit market. They explain that the timing is uncertain, but the process is progressing steadily, and the DEA's response is expected to align with the HHS recommendation. Regarding enforcement, they clarify that the DEA's focus is primarily on illicit grows and that the rescheduling would not change the current restrictions on state-legal cannabis businesses.The episode concludes with a discussion about the future of the cannabis industry and the investment landscape. The team encourages investors to consider the long-term potential of the industry and the progress being made in terms of federal reform. They acknowledge the challenges and uncertainties but emphasize the historic nature of the current developments and the opportunities for growth and success in the industry.Overall, the episode provides a comprehensive analysis of the recent recommendation to reschedule cannabis and offers insights into the potential implications for the cannabis industry. The NCR team's expertise and knowledge contribute to a nuanced and informative discussion that will be valuable for industry professionals, investors, and anyone interested in the evolving landscape of cannabis policy.https://nationalcannabisroundtable.org/00:00:14 - Introduction to the Podcast00:00:25 - National Cannabis Roundtable Guests00:00:57 - HHS Recommendation on Cannabis Scheduling00:02:03 - Why Not Deschedule Cannabis?00:03:41 - Release of Documents Under FOIA00:05:07 - No Confirmation on DEA's Stance Yet00:05:58 - Historical Precedent for DEA Recommendations00:08:36 - Attorney General's Position on Cannabis Enforcement00:12:06 - HHS's Analysis and Schedule III Criteria00:13:04 - Significance of HHS's Acknowledgment of Medical Use00:16:16 - Audience Questions: DEA's Timeline and Public Comment Period00:22:16 - DEA Funding and Enforcement Post-Scheduling Change00:26:55 - Public Discourse Impact on DEA Reaction00:31:10 - Investment Considerations in the Cannabis Industry00:37:11 - DEA's Potential Reaction to Public Discourse and Illicit Market Enforcement00:40:09 - DEA Funding Concerns and Illicit Market Enforcement Post-Scheduling Change00:42:51 - DEA's Reaction to Public Discourse on Cannabis Scheduling00:48:12 - Investment Strategy in the Current Cannabis Industry Climate00:52:54 - How to Get in Touch with NCR and Closing RemarksQuotes:"Hey everybody and welcome back to another episode of the Proud to Work in Cannabis podcast." - 00:00:14-00:00:24"This is exciting because a lot of the work that we've been doing is starting to really start to pay off." - 00:00:35-00:00:46"So on Friday, the U.S. government released hundreds of pages of documents related to its ongoing review of cannabis status under federal law." - 00:01:07-00:01:18"This is really a big deal because this is the first time that a government entity has come out and confirmed that we want to move cannabis from Schedule 1 to Schedule 3." - 00:01:29-00:01:39"The fact that we did get confirmation from Health and Human Services that a Schedule III was a recommendation is not only historic and outstanding, but it really was what the criteria would have allowed us to get to." - 00:03:10-00:03:20"The release of the documentation was actually the result of a request under something called the Freedom of Information Act or FOIA." - 00:03:41-00:03:52"The largest health agency in the U.S., globally recognized, has determined a medical significance, its currently accepted medical use of cannabis, and gone through its analysis in our favor." - 00:05:17-00:05:28"I can't imagine a scenario where this would be different. Of course, there is a possibility, and in fact, this document even makes note of this on the first page." - 00:07:57-00:08:07"It is pretty illogical to think that his position would change now that there is this acknowledgment by another federal agency." - 00:09:24-00:09:34"This is unprecedented, where you have such an established regulated industry for something that is scheduled in this way, that then is trying to move, move down." - 00:13:15-00:13:25 Produce By PodConxKarson Humiston - https://www.linkedin.com/in/karson-humiston-64572b97/Vangst - https://vangst.com/Recorded on SquadcastSound Design by Jamie Humiston

Dr. Fred Rottnek is a Professor and the Director of Community Medicine at Saint Louis University School of Medicine and the Program Director of the Saint Louis University Addiction Medicine Fellowship. His clinical practices currently include addiction medicine and correctional healthcare. He teaches in the School of Medicine, the Physician Assistant Program, and the School of Law. Board-Certified in Family Medicine and Addiction Medicine, he is the Medical Director for the Assisted Recovery Centers of American (ARCA) and Juvenile Detention in Family Court for the City of St. Louis. He serves on the boards of the Saint Louis Regional Health Commission and Alive and Well Communities.  Email: Fred.Rottnek@health.slu.edu The funder of this project, along with all other products of the Mid-America PTTC is the Substance Abuse and Mental Health Services Administration. Although funded by SAMHSA, the content of this recording does not necessarily reflect the views of SAMHSA. The human brain is the most complex organ in the body. Drugs can alter important brain areas that are necessary for life-sustaining functions and can drive the compulsive drug use that marks addiction. The National Institute on Drug Abuse (NIDA) has a great recourse available titled Drugs, Brains, and Behavior: The Science of Addiction. For more information visit -  https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/drugs-brain It is reported that only 25% of parents speak with their children about the dangers of drugs. How can we educate parents on the dangers of drugs and alcohol, and provide them with the tools needed to guide and engage children through this very rough and sensitive terrain? Addiction is Real can help answer this simple question – to learn more visit www.addictionisreal.org  We'd like to hear from you, please send your comment, topic or guest suggestion to midamericapttc@gmail.com

Dr. Wilson M. Compton serves as the Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. NIDA is the world's largest funder of research on health aspects of drug use and addiction, including research related to preventing drug use, treating addiction and addressing the serious health consequences of drug use. In his current role, Dr. Compton's responsibilities include working with the Director to provide scientific leadership in the development, implementation, and management of NIDA's research portfolio in order to improve the prevention and treatment of drug use and addiction. Today on the show we discuss: why cannabis should be taken seriously, how cannabis impacts anxiety and mental health, why kids should stay away from cannabis, advice for parents for navigating cannabis use with kids, how cannabis use can lead to psychosis and why young men could be more at risk, what epidemiological research reveals about cannabis use and more. Resources mentioned: https://nida.nih.gov/research-topics/parents-educators https://www.samhsa.gov/families ⚠ WELLNESS DISCLAIMER ⚠ Please be advised; the topics related to health and mental health in my content are for informational, discussion, and entertainment purposes only. The content is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek the advice of your health or mental health professional or other qualified health provider with any questions you may have regarding your current condition. Never disregard professional advice or delay in seeking it because of something you have heard from your favorite creator, on social media, or shared within content you've consumed. If you are in crisis or you think you may have an emergency, call your doctor or 911 immediately. If you do not have a health professional who is able to assist you, use these resources to find help: Emergency Medical Services—911 If the situation is potentially life-threatening, get immediate emergency assistance by calling 911, available 24 hours a day. National Suicide Prevention Lifeline, 1-800-273-TALK (8255) or https://suicidepreventionlifeline.org.  SAMHSA addiction and mental health treatment Referral Helpline, 1-877-SAMHSA7 (1-877-726-4727) and https://www.samhsa.gov and https://www.samhsa.gov Learn more about your ad choices. Visit megaphone.fm/adchoices

On episode 17 of A Chat with Uma, I provide a full recap of my experience at the Psychedelic Science 2023 conference in Denver, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS)! PS2023 was the world's largest-EVER gathering focused on psychedelic research and medicine, with over 12,000 attendees from across the globe. This episode provides a recap of my experience at the conference, ranging from research updates, OCD advocacy and awareness, my presentation experiences, key takeaways from sessions, and general meta updates from the psychedelic science field. This robust episode goes deep into the human experience of not only this conference, but the full-circle experience of finding myself in this space, participating in this way. I also speak in depth about the Intercollegiate Psychedelics Network (IPN), the premier student and youth-led psychedelic organization, where we empower, develop, and connect the next generation of students & rising professionals in the psychedelic ecosystem. IPN provides high-impact and interdisciplinary programming geared toward professional development, mentorship, and accessibility for members worldwide, and I provide context on my involvement as co-director and how our work contributed to the PS 2023 conference. Finally, I share my reflections and resolutions for moving forward beyond this conference. Topics Discussed (+ timestamps): (00:00:00) Intro: Check-in Introducing Psychedelic Science 2023 (00:08:36): Background on my path to the psychedelic field + this conference Contextual episodes: 01. My Full Story: 0 to 26 05. Yes, I've Done Psychedelics: From Psychonaut to Researcher 06. The Ketamine Diaries, Pt. 1 07. The Ketamine Diaries, Pt. 2 How my lived experience led me to Psychedelic Science 2019 How PS2019 influenced me going back to school The full-circle nature of sharing my own research at PS2023 (00:27:22): All about the Intercollegiate Psychedelics Network (IPN) What IPN is How it changed my life Winning PsychedelX 2022 Becoming IPN's co-director (00:41:32): IPN's contribution to Psychedelic Science 2023 Exhibiting Sponsor Booth "So, You Want To Be A Psychedelic Professional?" panel Students & Rising Professionals Mixer (00:49:28): RECAP: Psychedelic research funding from the NIH (& National Institute of Drug Abuse [NIDA]) (01:04:14): RECAP: Changing the paradigm of research collaboration vs. competition in psychedelic science; recommendations from experts (01:09:33): RECAP: Keynote from Dr. Andrew Huberman (Huberman Lab Podcast) - Shutting down animal work post psychedelic treatments; Contributions of students (01:19:26): RECAP: Launch of the ⁠Psychedelics & Pain Association (PPA)⁠; Psychedelics & Pain Symposium | July 15-16 (USE CODE 'umapod20' for 20% off tickets!) (01:27:21): RECAP: Updates from Yale Psilocybin & OCD trial(s) (01:31:59): RECAP: OCD advocacy & awareness through presenting my research (01:38:47): RECAP: IPN panel + mixer; Advocating for non-traditional + underrepresented students in the psychedelic ecosystem; Experiencing the next generation of the psychedelic field! Links mentioned in episode: Intercollegiate Psychedelics Network (IPN): Become a member for FREE! PsychedelX 2023 Tickets: Free + donation-based Psychedelics & Pain Symposium | July 15-16: USE CODE 'umapod20' for 20% off tickets! Psychedelics & Pain Association (PPA) Connect with me! My website⁠: ⁠⁠⁠⁠⁠⁠⁠⁠⁠umarchatterjee.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠@UmaRChatterjee⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠@UmaRChatterjee⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠@UmaRChatterjee⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: ⁠⁠⁠⁠⁠⁠⁠⁠⁠hello@umarchatterjee.com⁠⁠⁠⁠ Have a guest you want on the show? Fill out the ⁠⁠⁠Guest Suggestion Form!⁠ --- Send in a voice message: https://podcasters.spotify.com/pod/show/umarchatterjee/message

Nora D. Volkow, M.D., is a researcher and psychiatrist. She is the Director of the National Institute on Drug Abuse (NIDA) soon to be the  National Institute on Drugs and Addiction at the National Institutes of Health (NIH). NIDA is the world's largest funder of scientific research on the health aspects of drug use and addiction. Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a brain disorder. She pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.  Dr. Volkow was born in Mexico and grew up in Mexico City. She earned her medical degree from the National University of Mexico in Mexico City. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States.

Dr. Nora Volkow is a Psychiatrist and the Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. She joins Explore The Space Podcast for a powerful discussion on the impact of synthetic opioids on the risk of overdose and unintentional death, the massive impact of Social Determinants of Health, and the importance of providing medication as part of the treatment of opioid use disorder. Check out the archive of Explore The Space Podcast The Explore The Space Merchandise Store is open! Please check it out Please subscribe to and rate Explore The Space on Apple Podcasts or wherever you download podcasts. Email feedback or ideas to mark@explorethespaceshow.com Follow on Twitter @ETSshow, Instagram @explorethespaceshow Links NIDAMed: Clinical resources for health professionals and those in training about screening, addressing, and treating addiction NIDA's website SAMHSA's website

Welcome back for part 2 of our discussion on the National Institute's of Health HEALing Communities Study—a bold research effort that looks to reduce opioid-related overdose deaths across highly impacted communities by 40% over three years. Continuing the conversation from Part 1, we look to understand the progress the study has made to date, how the study's researchers have worked alongside their participating communities to adapt to the rapidly evolving drug landscape, and how the country can continue addressing the crisis.Dr. Redonna Chandler is the HEALing Community Study Director at the National Institute on Drug Abuse (NIDA). She has been at NIDA since 2002, serving in positions of increasing responsibility and leadership across the institute.Dr. Ynvild Olsen is Director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Administration (SAMHSA). She has previously worked in substance use treatment with Baltimore City and served as Deputy Health Officer for Maryland's Harford City Health Department.

Our last episode was a Rebeat of “The Game has Changed”, one of our earliest and most listened to episodes that explored medication assisted treatment (MAT) for opioid use disorder. A LOT has changed since we first published the episode in 2018! In this follow up episode, addiction medicine specialist, Dr. Aimee Moulin, talks to us about what's new, including modifying treatment for people using fentanyl; and what's old news - the X waiver!   How do you manage opioid use disorder in your practice? Share your experiences with us on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Dr. Julia Magaña, Associate Professor of Pediatric Emergency Medicine at UC Davis Guests: Dr. Aimee Moulin, Professor of Emergency Medicine and Chief of the Division of Addiction Medicine at UC Davis Resources: CA Bridge National Institute on Drug Abuse (NIDA) information on opioids Buprenorphine vs. Methadone on atforum.com Screening Brief Intervention & Referral to Treatment (SBIRT) *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

In 2018, the National Institutes of Health launched the HEALing Communities Study, a research endeavor to reduce opioid-related overdose deaths across highly impacted communities by 40% over three years. The study bridges science-driven interventions with community collaboration. In the first part of this special two-part episode, we chat with leadership behind the HEALing Communities Study about the evolution of the opioid crisis to date and how they're bridging compassion, research, and change to help communities hard-hit by opioid misuse and overdoses.Dr. Redonna Chandler is the HEALing Community Study Director at the National Institute on Drug Abuse (NIDA). She has been at NIDA since 2002, serving in positions of increasing responsibility and leadership across the institute.Dr. Yngvild Olsen is Director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Administration (SAMHSA). She has previously worked in substance use treatment with Baltimore City and served as Deputy Health Officer for Maryland's Harford City Health Department.

In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators. That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of an industry many are flocking to without realizing what they'll likely have to deal with: unprecedented legal and financial risks, burnout, misalignment with management, transference and countertransference, and what happens when one finds themselves in the middle of a genuine emergency? While these issues could be found in any industry, a big reason why they seem so prevalent and dangerous in the psychedelic world is our lack of elders and passed-down experience – and the faster this all grows, the more we need that guidance.  And for news, they talk about Ohio State making history as the first U.S. University to receive a license to grow psilocybin mushrooms; a new study showing that LSD enhanced learning, exploratory thinking, and sensitivity to feedback; and the National Institute on Drug Abuse (NIDA) funding $1.5 million to research the efficacy of psychedelics for substance use disorder – which spurs a conversation about research, funding, and the idea that maybe we're spending too much time and money on neuroscience. www.psychedelicstoday.com

Brought to you by Athletic Greens's AG1 all-in-one nutritional supplement, House of Macadamias delicious and nutritious nuts, and Eight Sleep's Pod Cover sleeping solution for dynamic cooling and heating. Nora D. Volkow, MD, is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world's largest funder of scientific research on the health aspects of drug use and addiction. Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.Please enjoy!This episode is brought to you by Eight Sleep! Eight Sleep's Pod Cover is the easiest and fastest way to sleep at the perfect temperature. It pairs dynamic cooling and heating with biometric tracking to offer the most advanced (and user-friendly) solution on the market. Simply add the Pod Cover to your current mattress and start sleeping as cool as 55°F or as hot as 110°F. It also splits your bed in half, so your partner can choose a totally different temperature.Go to EightSleep.com/Tim and save $250 on the Eight Sleep Pod Cover. Eight Sleep currently ships within the USA, Canada, the UK, select countries in the EU, and Australia.*This episode is also brought to you by Athletic Greens. I get asked all the time, “If you could use only one supplement, what would it be?” My answer is usually AG1 by Athletic Greens, my all-in-one nutritional insurance. I recommended it in The 4-Hour Body in 2010 and did not get paid to do so. I do my best with nutrient-dense meals, of course, but AG1 further covers my bases with vitamins, minerals, and whole-food-sourced micronutrients that support gut health and the immune system. Right now, Athletic Greens is offering you their Vitamin D Liquid Formula free with your first subscription purchase—a vital nutrient for a strong immune system and strong bones. Visit AthleticGreens.com/Tim to claim this special offer today and receive the free Vitamin D Liquid Formula (and 5 free travel packs) with your first subscription purchase! That's up to a one-year supply of Vitamin D as added value when you try their delicious and comprehensive all-in-one daily greens product.*This episode is also brought to you by House of Macadamias delicious and nutritious nuts! I love macadamia nuts and have been enjoying them often since keto expert Dr. Dominic D'Agostino recommended them on the podcast in 2015. They taste great, and with more healthy, monounsaturated fat than both olive oil and avocados, 27% fewer carbs than almonds, and more than 50% fewer carbs than cashews, they're the perfect low-carb, keto-friendly, nutty snack. In fact, I just ate a handful of lightly white-chocolate-covered macadamias about an hour ago to keep me going through the afternoon until dinner. And I will say this: ​House of Macadamias produces the best-tasting macadamia nuts I've ever eaten… by far.​Now, listeners of The Tim Ferriss Show podcast can use code TIM20 to get 20% off all orders and a free box of their best-selling Namibian sea-salted macadamia nuts worth $35! If these are not the best macadamia nuts you have ever eaten, House of Macadamias will give a full 100% refund, guaranteed.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, Margaret Atwood, Mark Zuckerberg, Peter Thiel, Dr. Gabor Maté, Anne Lamott, Sarah Silverman, Dr. Andrew Huberman, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's time for another Rebeat! We're revisiting one of our favorite episodes from our very first season. The opioid epidemic is still very real and there are some new challenges with fentanyl as the predominant opioid on the street. But we've gained experience with medication assisted treatment (MAT) and it is now even easier to prescribe treatment for opioid use disorder. The Rebeat has been edited to reflect some of these changes, and our next episode will provide an update on MAT. Now on to the Rebeat… Let's talk about the opioid crisis. One woman tells her powerful story of opioid addiction, treatment, and recovery. Then, we discuss the role emergency physicians can play in controlling this epidemic with experts, Dr. Gail D'Onofrio and Dr. Josh Elder.  How do you manage opioid use disorder in your practice? Join the conversation on Social Media @empulsepodcast or at ucdavisem.com Hosts: Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Dr. Julia Magaña, Associate Professor of Pediatric Emergency Medicine at UC Davis Guests: Dr. Gail D'Onofrio, Professor of Emergency Medicine, Professor of Chronic Disease Epidemiology, and Professor of Internal Medicine, Core Faculty in Addiction, at Yale School of Medicine Dr. Josh Elder, Former Assistant Professor of Emergency Medicine at UC Davis Health Resources: Screening Brief Intervention & Referral to Treatment (SBIRT) CA Bridge National Institute on Drug Abuse (NIDA) information on opioids Buprenorphine vs. Methadone on atforum.com Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. D'Onofrio G, O'Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. JAMA. 2015 Apr 28;313(16):1636-44. doi: 10.1001/jama.2015.3474. PMID: 25919527  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention. D'Onofrio G, Chawarski MC, O'Connor PG, Pantalon MV, Busch SH, Owens PH, Hawk K, Bernstein SL, Fiellin DA. J Gen Intern Med. 2017 Jun;32(6):660-666. doi: 10.1007/s11606-017-3993-2. Epub 2017 Feb 13. PMID: 28194688 Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Busch SH, Fiellin DA, Chawarski MC, Owens PH, Pantalon MV, Hawk K, Bernstein SL, O'Connor PG, D'Onofrio G. Addiction. 2017 Nov;112(11):2002-2010. doi: 10.1111/add.13900. Epub 2017 Aug 16. PMID: 28815789 Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

In this episode, Sara Hairgrove talks with Dr. Sarah Steverman, a Social Behavioral Scientist Administrator in the Prevention Research Branch at the National Institute on Drug Abuse (NIDA). NIDA's mission is to advance science on the causes and consequences of drug use and use disorders, and to apply that knowledge to improve individual and public health. Dr. Steverman describes the career journey that led her to contributing to prevention science from a position in the federal government and how her less traditional career path and varied experiences really helped her focus in on the type of work she wanted to do, even if it took her a little longer to get to where she is today. Her motivation to do prevention research stems from being a partner and mother and wanting every community to have the resources to ensure that parents and children are healthy and have the best outcomes possible. Dr. Steverman offers important advice for young women aspiring to work in the prevention field, or in prevention for the federal government. She suggests that young women talk to people about their careers and she wants them to know that you don't have to have a PhD to do meaningful prevention science that you're passionate about. The views expressed in this podcast are those of the participants and not the official views of NIH, the NIH HEAL Initiative, NIDA, or the participating institutions and organizations.

Addiction Medicine is Family Medicine! is part of the Treating Addiction in Primary Care series. Carol Havens, MD interviews Mario San Bartolome, MD, MBA, MRO, FASAM This episode features two recognized leaders in addiction medicine sharing their thoughts about why Family Physicians need to offer treatment services, what to address as you begin, and how rewarding it is to see the positive impacts in their communities. Addiction medicine is family medicine. On the Podcast: Carol Havens, MD recently retired as Director of Physician Education and Development at the Kaiser Permanente Medical Care Program, Northern California Region. She was a staff physician in Kaiser's Chemical Dependency and Recovery Program. She is past president of CAFP, and co-chair of the CAFP Education Committee. Mario San Bartolome, MD, MBA, MRO, FASAM serves vulnerable populations through FQHCs in Orange County, and is very active in both the American Society of Addiction Medicine and California Society of Addiction Medicine, where he serves on the Board of Directors.  Rob Assibey, MD, hosts. For full bios of speakers, please visit: www.familydocs.org/podcast. Resources: CAFP - CA Academy of Family Physicians, Substance Use Disorder: education, resources, projects, and peer support https://familydocs.org/sud CA Bridge: training, information, and advocacy across California and beyond https://cabridge.org CSAM - CA Society of Addiction Medicine: gatherings, education, resources, and policy https://csam-asam.org  NCCC California Substance Use Line: 24/7 confidential provider tele-consultation for SUD https://nccc.ucsf.edu/clinician-consultation/substance-use-management/california-substance-use-line/ 844-326-2626 PCSS - Providers Clinical Support System: SAMHSA program to train primary care providers about OUD and treatment of chronic pain https://pcssnow.org/  Thanks: The Family Docs Podcast series Treating Addiction in Primary Care is supported by the National Institute on Drug Abuse (NIDA) and the California Department of Health Care Services (DHCS). Thanks to Shatterproof for sharing ambassador voices. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs Instagram - https://www.instagram.com/cafp_familydocs Facebook - https://www.facebook.com/familydocs

Prescribing Medication for Opioid Use Disorder is part of the Treating Addiction in Primary Care series. Tipu Khan, MD, FAAFP, FASAM interviewing Rebecca Trotzky-Sirr, MD Our guests explain the different OUD medicines - there are three and really only two used in primary care - and guide you through very specific resources and protocols so you can get started saving lives right away.  On the Podcast: Tipu Khan, MD, FAAFP, FASAM is Primary Care Addiction Medicine Fellowship Program Director and Core Faculty, Family Medicine Residency as well as Adjunct Associate Clinical Professor at USC Keck School of Medicine, and Ventura Family Medicine Residency Program/UCLA. Rebecca Trotzky-Sirr, MD is Medical Director of the Urgent Care Center at LAC + USC and is faculty in the Department of Emergency Medicine at USC. She is the Southern California Regional Coordinator for CA Bridge. Rob Assibey, MD, hosts. For full bios of speakers, please visit: www.familydocs.org/podcast. Resources: CAFP - CA Academy of Family Physicians, Substance Use Disorder: education, resources, projects, and peer support https://familydocs.org/sud CA Bridge: training, information, and advocacy across California and beyond https://cabridge.org 2023 X-Waiver Update, CA Bridge: fewer barriers to prescribing buprenorphine https://cabridge.org/general/critical-updates-about-the-x-waiver-removal/  PCSS - Providers Clinical Support System: SAMHSA program to train primary care providers about OUD and treatment of chronic pain https://pcssnow.org/  NCCC California Substance Use Line: 24/7 confidential provider tele-consultation for SUD https://nccc.ucsf.edu/clinician-consultation/substance-use-management/california-substance-use-line/ 844-326-2626 Thanks: The Family Docs Podcast series Treating Addiction in Primary Care is supported by the National Institute on Drug Abuse (NIDA) and the California Department of Health Care Services (DHCS). Thanks to Shatterproof for sharing ambassador voices. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs Instagram - https://www.instagram.com/cafp_familydocs Facebook - https://www.facebook.com/familydocs

Break the Stigma, Save a Life is part of the Treating Addiction in Primary Care series. M. Shoaib Khan, MD, AAHIVS interviews Sky Lee, MD, AAHIVS and MK Orsulak, MD, MPH, AAHIVS Health care providers may still blame patients for their substance use disorder (SUD) even though we know that addiction is a brain disorder and not the result of moral weakness. This episode dives deep into the origins of SUD stigma and how it merged with racism in the U.S. to influence drug policy and treatment. We'll discuss harm reduction and how to promote health and dignity with people who use drugs. On the Podcast: M. Shoaib Khan, MD, AAHIVS is core faculty at UCSF Fresno with a focus on underserved populations in the San Joaquin Valley area. Sky Lee, MD, AAHIVS works with people who are incarcerated. Previously she was on the faculty of UC Davis Medical Center, and worked with the CA Bridge program. MK Orsulak, MD, MPH, AAHIVS serves patients at the Sacramento County Primary Care Clinic, Mercy Clinic at Loaves and Fishes, and the Sacramento County Department of Public Health Sexual Health Clinic. She is an attending on the inpatient UC Davis Substance Use Intervention Team. Rob Assibey, MD, hosts. For full bios of speakers, please visit: www.familydocs.org/podcast. Resources: CAFP - CA Academy of Family Physicians, Substance Use Disorder: education, resources, projects, and peer support https://familydocs.org/sud NCCC California Substance Use Line: 24/7 confidential provider tele-consultation for SUD https://nccc.ucsf.edu/clinician-consultation/substance-use-management/california-substance-use-line/ 844-326-2626 CA Bridge: training, information, and advocacy across California and beyond https://cabridge.org National Harm Reduction Coalition: to increase access to strategies like overdose prevention and syringe access programs https://harmreduction.org/  Bevel Up: safer use, overdose prevention & other harm reduction tips https://www.bvlup.com/  Thanks: The Family Docs Podcast series Treating Addiction in Primary Care is supported by the National Institute on Drug Abuse (NIDA) and the California Department of Health Care Services (DHCS). Thanks to Shatterproof for sharing ambassador voices. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs Instagram - https://www.instagram.com/cafp_familydocs Facebook - https://www.facebook.com/familydocs  

The Time for Treating Substance Use Disorder is Now is part of the Treating Addiction in Primary Care series. Raul Ayala, MD interviews Arianna Campbell, PA-C Why should family doctors - and all primary care providers - integrate treatment for opioid use disorder (OUD) into our practice? You'll hear first-hand accounts of how medication for opioid use disorder (MOUD) enriches practice, relationships with patients, and most importantly, saves lives. We'll identify barriers to beginning MOUD and start you on your way to office based opioid treatment (OBOT). On the Podcast: Raul Ayala, MD, is Ambulatory Medical Director at Adventist Health Central Valley Network and an active member of Adventist's Opioid Stewardship Committee. Beginning March 2023, he is President of the California Academy of Family Physicians. Arianna Campbell, PA-C, is an Emergency Department PA. She is co-founder, Director, and co- Principal Investigator for CA Bridge, making it possible for people who use drugs to get treatment at any hospital—whenever and wherever they need it. Rob Assibey, MD, hosts. For full bios of speakers, please visit: www.familydocs.org/podcast. Resources: CAFP - California Academy of Family Physicians, Substance Use Disorder: education, resources, projects, and peer support https://familydocs.org/sud CA Bridge: training, information, and advocacy across California and beyond https://cabridge.org CSAM - CA Society of Addiction Medicine: gatherings, education, resources, and policy https://csam-asam.org  MERF - Medical Education and Research Foundation for the Treatment of Addiction: training and scholarships https://merfweb.org  Shatterproof.org - Patient stories are compliments of Shatterproof, a national nonprofit organization dedicated to reversing the addiction crisis in the United States. Thanks: The Family Docs Podcast series Treating Addiction in Primary Care is supported by the National Institute on Drug Abuse (NIDA) and the California Department of Health Care Services (DHCS). Thanks to Shatterproof for sharing ambassador voices. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs Instagram - https://www.instagram.com/cafp_familydocs Facebook - https://www.facebook.com/familydocs

Will NIDA get rid of the word "Abuse" and go from National Institute on Drug Abuse to National Institute on Drugs and Addiction? Should people get a prescription to buy a vape pen? What is the science on label for marijuana products? Dr. Nora Volkow, director of NIDA shares her hopes for 2023 and discusses the science behind drug addiction. Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world's largest funder of research on the health aspects of drug use and addiction. Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented that changes in the dopamine system affect the functions of frontal brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging. Dr. Volkow was born in Mexico and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins Award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States. Much of her professional career was spent at the Department of Energy's Brookhaven National Laboratory in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. Dr. Volkow was also a professor in the Department of Psychiatry and Associate Dean of the Medical School at The State University of New York at Stony Brook. Dr. Volkow has published more than 800 peer-reviewed articles, written more than 100 book chapters, manuscripts and articles, co-edited "Neuroscience in the 21st Century" and edited four books on brain imaging for mental and addictive disorders. She received a Nathan Davis Award for Outstanding Government Service, was a Samuel J. Heyman Service to America Medal (Sammies) finalist and is a member of the National Academy of Sciences and the Association of American Physicians. Dr. Volkow received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science; was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University; and was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was named one of Time magazine's "Top 100 People Who Shape Our World"; one of "20 People to Watch" by Newsweek magazine; Washingtonian magazine's "100 Most Powerful Women"; "Innovator of the Year" by U.S. News & World Report; and one of "34 Leaders Who Are Changing Health Care" by Fortune magazine.

Michael Walsh speaks with Dr. Antonello Bonci on today's episode. Dr. Bonci is the President, Chief Scientific Officer & Partner at GIA Chicago. Before moving to GIA Miami, he served for nearly a decade at the National Institute of Health (NIH) as Scientific Director of the National Institute on Drug Abuse (NIDA). Between 1999 and 2010, he was Professor-in-Residence in the Department of Neurology at the University of California, San Francisco (UCSF), and held the Howard J. Weinberg Endowed Chair in Addiction Research while also serving as Associate Director for Extramural Affairs at the Ernest Gallo Clinic and Research Center. Over the last 5 years, Dr. Bonci and his collaborators worldwide have successfully pioneered the translation of non-invasive brain stimulation such as Transcranial Magnetic Stimulation (TMS), from the preclinical stage to the clinic, to treat cocaine use disorders and other types of addiction.

Robby and Sammi want to welcome you to a Very Special Episode of The Painful Truth of Living with Chronic Pain where as they discuss Substance Use Disorders aka addiction. You've heard about Robby's struggles with opioids, and on the next episode you'll get a better understanding of their friend Phil's addiction history, so it seemed like a good time to dive into the topic. Robby has friends who currently struggle with illicit drug abuse and offers his own personal insight into caring for an addict while Sammi breaks down the medical jargon and advice.Follow your hosts on Instagram @thepainfultruthpodcast, @robert1950studios, and @thesam.a.lam!Follow Phil on Instagram @nocatsnoglory78 and TikTok @catsncannabisFind addiction and recovery help:National Institute on Drug Abuse (NIDA) - https://nida.nih.gov/SAMHSA's National Helpline - https://www.samhsa.gov/find-help/national-helpline1-800-662-4357Mayo Clinic - https://www.mayoclinic.org/diseases-conditions/drug-addiction/care-at-mayo-clinic/mac-20365117Follow your hosts on Instagram @thepainfultruthpodcast, @robert1950studios, and @thesam.a.lam!Join Ashley and Sammi for some Disney magic over on The Pixie Dust Twins Podcast!Support the show

Dr. Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), recently published an article in Health Affairs Magazine that many in the recovery community consider “a game changer” in how it challenged received wisdom and old assumptions in the treatment of addicted individuals. In this interview, Dr. Tom Horvath, co-founder of SMART Recovery, assesses the article's impact and how it may change the face of the recovery landscape forever.

In this Bell Works Talks, Dr. Nicole Short discusses findings from a large, multisite, prospective observational cohort study on the prevalence of acute and persistent pain post-sexual assault, and how posttraumatic stress symptoms may account for the transition from acute to chronic pain. She will focus on the clinical implication of these findings for healthcare providers working with sexual assault survivors. Nicole A. Short, PhD is an Assistant Professor of Anesthesiology at the University of North Carolina at Chapel Hill. She earned her PhD in clinical psychology from Florida State University in 2019 after completing her clinical internship at the Charleston Consortium. Dr. Short's research focuses on the etiology and prevention of trauma and anxiety-related disorders utilizing a translational approach. She is interested in identifying and characterizing cognitive-affective and other risk factors (e.g., anxiety sensitivity, sleep disturbance) for the development of posttraumatic stress and related symptoms (e.g., substance use disorder); better understanding how these risk factors relate to underlying biological processes; and utilizing this knowledge to develop novel preventions and treatments for these disorders, particularly by leveraging technology-based interventions. She is especially interested in improving mental health and substance use outcomes post-sexual assault. She has published over 70 peer-reviewed articles in these areas, and has received funding from the National Institute on Drug Abuse (NIDA), American Psychological Foundation, and MayDay Fund to support her work. Clinically, Dr. Short is a licensed psychologist focused on cognitive behavioral treatments for posttraumatic stress, anxiety, and sleep disturbance, as well as comorbid chronic pain. Resources: Short, N. A., Tungate, A. S., Bollen, K. A., Sullivan, J., D'Anza, T., Lechner, M., ... & McLean, S. A. (2022). Pain is common after sexual assault and posttraumatic arousal/reactivity symptoms mediate the development of new or worsening persistent pain. Pain, 163(1), e121-e128. McLean, S. A., Soward, A. C., Ballina, L. E., Rossi, C., Rotolo, S., Wheeler, R., ... & Liberzon, I. (2012). Acute severe pain is a common consequence of sexual assault. The Journal of Pain, 13(8), 736-741. Ulirsch, J. C., Ballina, L. E., Soward, A. C., Rossi, C., Hauda, W., Holbrook, D., ... & McLean, S. A. (2014). Pain and somatic symptoms are sequelae of sexual assault: results of a prospective longitudinal study. European journal of pain, 18(4), 559-566. Better Tomorrow Network: https://www.med.unc.edu/itr/better-tomorrow-network/

Today we take a look at the National Institute on Drug Abuse (NIDA) website to see what, if any, studies they cite that provide evidence that kratom can be directly linked to respiratory depression. (*Sources in this episode can be found below.) * https://dsh.re/a01a1 * https://dsh.re/45950 * https://dsh.re/e21fe * https://dsh.re/9bd56 Please support this podcast here! https://www.paypal.me/everythingkratom or here! https://anchor.fm/everything-kratom/support Get 25% off orders from ETHA Natural Botanicals with coupon code EVERYTHINGKRATOM, or visit their website using this link - https://ethalivefully.com/discount/EVERYTHINGKRATOM?aff=243 Mine Bitcoin in the background while you browse the web with CryptoTab! Use this link and we'll both get some Bitcoin! https://cryptotabbrowser.com/29834446 Join Acorns with this link and you'll get a free $5 investment! https://share.acorns.com/jamisonlerner?advocate.partner_share_id=5486350520189770190 Join Robinhood with this link and we'll both pick our own free stock! https://join.robinhood.com/jamisol39 Available wherever you get your podcasts: Anchor - https://anchor.fm/everything-kratom Spotify - https://open.spotify.com/show/2fO3Xsx1BbNUs2rpXiQs3s Google Podcasts - https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy82OWUxMzZjNC9wb2RjYXN0L3Jzcw== Apple Podcasts - https://podcasts.apple.com/us/podcast/everything-kratom/id1584592399 Pocket Casts - https://pca.st/mql8q14u RadioPublic - https://radiopublic.com/everything-kratom-WzkkBK Overcast - https://overcast.fm/itunes1584592399/everything-kratom Reason - https://reason.fm/podcast/everything-kratom?user=16e32b81-d623-4dcd-a000-623566fdc41a YouTube Channel: https://www.youtube.com/channel/UCUsCC1nBchi_xMX9wRyQ_nA Website: https://everythingkratom279311648.wordpress.com Thank you all so much for listening! --- Send in a voice message: https://anchor.fm/everything-kratom/message Support this podcast: https://anchor.fm/everything-kratom/support

Dr. Nora Volkow recently spoke to the SMART Recovery community about the National Institute on Drug Abuse (NIDA) holistic approach to helping those with substance use issues. As a follow up to that conversation, we talked with Dr. Wilson Compton, Deputy Director of NIDA and Dr. Will Aklin, Director of the Behavioral Therapy Development Program, about research on the health aspects and treatment of substance use disorders. In this podcast, they talk about: How their college professors got them excited and passionate about careers in scientific research Medications that help with various addictions, including a new focus on stimulant use disorders Bridging the gap between treatment and recovery Individualized, personal treatments Examples of harm reduction measures Creating a net positive to society The four pillars of overdose strategy: primary prevention, harm reduction, evidence-based treatment, and recovery support Explaining value of CBT and MAT How research helps us understand the impact of mutual support and recovery The research behind using Contingency Management to shape positive behavior Making treatment less intimidating and more welcoming Working across boundaries and departments, within the government, to address the drug abuse problems and find solutions

Dr. Kirsten Smith of National Institute on Drug Abuse (NIDA) joins us once again to talk about an upcoming comprehensive study that will include a detailed nationwide survey, testing of kratom samples, and testing select individual kratom consumers. We also cover several papers that Dr. Smith led or co-authored that have been published since her … 81. Dr. Kirsten Smith of NIDA Returns Read More » The post 81. Dr. Kirsten Smith of NIDA Returns first appeared on Kratom Science.

In this episode, Dr. Ryan Jackman gives us an overview of addiction in Rural America. He compares the rates of substance use and overdose deaths between urban and rural areas and reviews what factors might contribute to the development of use disorders in rural communities. Dr. Jackman also discusses the unique challenges rural areas face in obtaining treatment and how we can draw upon the strength and resiliency of their people to overcome some of these barriers. Dr. Ryan Jackman is a board-certified family medicine and addiction medicine physician who practices in Grand Junction, Colorado. He is the medical director of St. Mary's Integrated Addiction Medicine clinic and the project director for a HRSA funded Rural Communities Opioid Response Program serving Western Colorado. He has special interests in graduate medical education and increasing access to medical care in rural locations has received training awards from the National Institute on Drug Abuse (NIDA) in 2016 and the Colorado Health Foundation and Denver Foundation in 2017 to implement tele-addiction medicine in Western Colorado.Take a look at some of resources Dr. Jackman referenced:https://www.cdc.gov/nchs/data/databriefs/db403-H.pdfhttps://www.cdc.gov/mmwr/volumes/68/wr/mm6817a3.htmhttps://opioidmisusetool.norc.org/https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1015&context=ruhrc_reportshttps://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1014&context=ruhrc_reportshttps://www.countyhealthrankings.org/app/colorado/2021/measure/factors/134/dataLearn more about Dr. Jackman at https://doctors.sclhealth.org/provider/Ryan+K.+Jackman/1617603

https://www.worldsbest.rehab/crack-addiction/ https://www.worldsbest.rehab/es/crack-addiction/ https://www.worldsbest.rehab/de/crack-addiction/ Understanding Crack Addiction & Rehab Treatment In 2014, it was estimated by the National Survey on Drug Use and Health (NSUDH) that over 21 million Americans 12-years old and older suffered from a substance abuse disorder. It is claimed that America losses around $600 billion per year due to substance abuse disorder.  Money is lost due to criminal justice costs, legal expenses, healthcare, and a lack of production in the workplace, according to the National Institute on Drug Abuse (NIDA). Crack cocaine is one drug that Americans are struggling with currently. It is a highly addictive drug and one that is very difficult to stop using cold turkey.  What is crack cocaine? One of the drugs that consistently leads to addiction in users is crack cocaine. Crack is a drug that is derived from cocaine. Often known as the “rich person's drug” cocaine is produced from the coca plant in South America. In its powder form, cocaine produces an intense high. It causes dopamine to flood the brain. The effects are immediate but short-lived resulting in users needing more and more cocaine to get high.  Crack is produced when powered cocaine is mixed with water and, most often, baking soda. The mixture is then boiled to form a solid substance. The substance is then cooled and broken into small pieces. These pieces are then sold by drug dealers as crack. The drug's name comes from its “cracking” sound when it is warmed and smoked.  Crack cocaine is extremely addictive. The reason why it is so addictive is due to its high concentration of ingredients. Just one use can make a person addicted to the drug.  Going to Rehab for crack cocaine addiction Although crack is highly addictive, there is help available to end an addiction to the deadly drug. Recovery is difficult and extremely taxing. It will test your physical and psychological make up. Ending your crack cocaine addiction alone is possible, but with professional help, you can end your dependence on the drug for good.  Rehab removes you from the environment of crack cocaine addiction. Many people struggling with addiction remain rooted in an atmosphere that fosters addiction. Rehab eliminates this atmosphere and provides an environment with support to end your need for the drug.  There are treatment centers that specialize in crack cocaine addiction. By seeking help from one of these expert institutions, you provide yourself with the tools needed to end crack's hold on your life.  Understadning the journey to a life after crack addiction After you decide to get help from a professional rehab, you will begin the journey to a life without crack cocaine. Once this step is taken, you will begin detox. A crack treatment center will provide you with a safe environment to detox off of the addictive drug.  Undergoing detox in a controlled environment allows you to safely remove the toxic drug from your body. Your mental health will be tested during this stage as depression and anxiety occur during the detox process.  The come down from crack cocaine addiction is steep. Many people want to end their crack cocaine addiction, but the fear of the mental and physical pain prevents them from entering the detox phase. Along with depression and anxiety, crack users experience strong cravings when they enter the come down.  Detox will produce withdrawal from crack. You will experience cravings, physical symptoms, and psychological symptoms. These symptoms may be intense and could last up to a month or more. However, most crack cocaine users go through the worst parts of withdrawal for three to seven days. Your detox and withdrawal will depend on your level and length of crack cocaine use.  The most common withdrawal symptoms from crack cocaine addiction include: Anxiety Intense cravings Extreme fatigue and tiredness Sleeplessness and insomnia Severe depression and sadness Nightmares The withdrawal period is very difficult. Unfortunately, many users do not want to go through withdrawal due to fear. This causes crack cocaine users to relapse. Returning to crack does not mean you failed in your bid to get clean, however. You should remember that the road to long-term sobriety is long and winding.  Understanding the different types of crack addiction rehab treatment There are different types of crack cocaine rehab options. Inpatient rehab is oftentimes seen as the best solution to an addiction to drugs and alcohol. Inpatient rehab facilities come in all shapes and sizes. There are also different rehab treatment plans that inpatient centers employ.  Some of the most common practices an inpatient crack cocaine rehab will use is cognitive behavioral therapy (CBT), one-to-one therapy, group therapy, support groups, and psychoeducational group sessions.  You will also find other treatment methods used at many inpatient crack cocaine rehab centers. These methods may include mindfulness and meditation, 12-step programming, off-site activities, and more. Most crack cocaine rehab programs will last 30 days, but depending on your level of addiction, you may be able to stay longer.  Never underestimate the importance of aftercare for Crack addiction after rehab Due to the level of addiction crack cocaine creates in users, your will likely need continued care post-rehab. A treatment center will help you adjust to life after addiction. Intensive therapy and counseling will help you cope with life and the challenges you face without drugs.  Some crack cocaine rehabs provide support in the form of vocational training. This helps you through the recovery process by teaching you skills for a work. Many former crack addicts have difficult reintegrating with society. Rehabs want to prevent an individual from relapsing and providing them with the skills to reintegrate into society aims to lower the chances for a relapse.  Support groups are available and give you the chance to speak with someone. Speaking to a support group may be the difference between using crack once more and staying sober. By building ties with a group or community after rehab, you give yourself the chance to remain clean and sober for the long-term.  If you are struggling with crack cocaine addiction, there is help for you. Inpatient rehab is the ideal way to end an addiction to crack and regain control of your life. Ending crack cocaine addiction is a long, difficult road. It will take mental and physical strength, and it is likely to need support from professionals at a cocaine rehab facility. If you want to begin the journey to being drug-free, then you can begin it today.   https://www/worldsbest.rehab/addiction-center/ https://www.worldsbest.rehab/  

Mike Ortoll's world was turned upside down when his daughter Christine started abusing drugs and alcohol. Christine found recovery for several years, but sadly suffered a relapse and passed away from a fentanyl overdose in late 2020. In grieving his daughter, Mike started to think about how he could share his experience with other families facing addiction. Through a series of high-profile documentary films, including the Bowden Dynasty Film and another film documenting Christine's story, Mike and a few of his Sigma Chi Fraternity Brothers are now providing support to the Collegiate Recovery Program at Florida State University (FSU), called LIFT. Mike also started the Christine Ortoll Recovery Organization to raise awareness, share resources, and lead a national “call to action” across the country of changing the conversation about addiction and recovery.The CDC has reported that more than 100,000 Americans died of a drug overdose in a 12 month period from 2020 to 2021, and many of those deaths have been attributed to Fentanyl. According to the Drug Enforcement Agency (DEA), Fentanyl is a synthetic opioid that is 80-100 times stronger than morphine. Fentanyl is often times added to heroin to increase its potency, or to be disguised as highly potent heroin. Many users believe they are purchasing heroin and don't know that they are actually purchasing fentanyl – which often results in overdose deaths.Christine Ortoll Recovery OrganizationAssociation of Recovery in Higher EducationLIFT at Florida State University (FSU)Center for Health Advocacy Wellness at FSUSubstance Abuse & Mental Health Services Administration (SAMHSA)National Institute on Drug Abuse (NIDA)www.tpoftampa.comwww.thepointisrecoverypodcast.comwww.facebook.com/TurningPointofTampawww.twitter.com/TurningPointTPAwww.instagram.com/turningpointtpawww.youtube.com/user/TurningPointofTampawww.linkedin.com/company/turning-point-of-tampa-inc

Listen to Dr. Nora Volkow’s discussion with Dr. Roneet Lev on the gold standard for addiction, substance use disorder treatment, innovations in drug treatment, naloxone, emergency treatment, stigma, decriminalization, marijuana, and more.  This podcast includes Dr. Nora Volkow  keynote presentation at the Western Regional Opioid & Stimulant Summit of November 2021. Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world's largest funder of research on the health aspects of drug use and addiction. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented that changes in the dopamine system affect the functions of frontal brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging. Dr. Volkow was born in Mexico and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins Award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States. Much of her professional career was spent at the Department of Energy's Brookhaven National Laboratory in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. Dr. Volkow was also a professor in the Department of Psychiatry and Associate Dean of the Medical School at The State University of New York at Stony Brook. Dr. Volkow has published more than 800 peer-reviewed articles, written more than 100 book chapters, manuscripts and articles, co-edited “Neuroscience in the 21st Century” and edited four books on brain imaging for mental and addictive disorders. She received a Nathan Davis Award for Outstanding Government Service, was a Samuel J. Heyman Service to America Medal (Sammies) finalist and is a member of the National Academy of Sciences and the Association of American Physicians. Dr. Volkow received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science; was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University; and was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was named one of Time magazine’s “Top 100 People Who Shape Our World”; one of “20 People to Watch” by Newsweek magazine; Washingtonian magazine's “100 Most Powerful Women”; “Innovator of the Year” by U.S. News & World Report; and one of “34 Leaders Who Are Changing Health Care” by Fortune magazine.

Words matter.There's no question about that – they're a big driving force of stigma, and it's always a  heated debate when it comes to semantics with these touchy areas. One of the many challenges is that while the healthcare guidelines move away from words like 'addict,' many popular 12-step fellowships have fully embedded that word into their culture, and a lot people choose to use it as a point of personal pride.But despite of this, in recent years the culture has been shifting heavily against the use of that word. For example, most dictionaries have replaced all instances of addict used as a noun with “a person addicted to” or a “habitual user of.”But why would a dictionary change a word that's been around for centuries? The way we use language evolves—and so do dictionaries. And when it comes to words around addiction, there's been a lot of evolution in recent years.Episode 19 discusses the National Institute of Drug Abuse (NIDA)'s recent updated guidelines on the language they recommend using and avoiding when talking about substance use disorders.In this show I'll provide a review of the recommendations, personal perspectives on the topic of language, and of course some relatively unrelated tangents and personal stories that you've come to expect from these episodes :-)If you enjoy the episode, leave a review, and share it with someone!Follow on Instagram at Reaction Recovery for daily topics.

Dr. Nora Volkow has headed the U.S. National Institute on Drug Abuse (NIDA), which funds a majority of the world's research in the area, since the early years of George W. Bush's administration. I was pleasantly surprised when she agreed to join me for an episode of PSYCHOACTIVE since I've been highly critical of the agency's priorities and its failure to fund important domains of research for what appear to be political reasons.I pressed Dr. Volkow on a host of questions I'd long wanted to ask her: Why does NIDA devote relatively little funding to the sorts of ethnographic research that might provide important insights into the overdose epidemic? Or to researching the health effects and consequences of mass arrests and incarceration for drug law violations? Or to studying the medical benefits of marijuana and psychedelics? Or to better understanding “controlled drug use,” i.e., the ways in which people use all sorts of drugs without their drug use becoming problematic? Or to examining the potential of supervised injection facilities, heroin-assisted drug treatment and other innovative harm reduction interventions that have proven successful abroad?I also wanted to know how she's managed the political challenges of working under four different administrations as well as those presented by members of Congress who favor highly punitive approaches to illicit drug use. We discussed her frustrations with current laws that constrain what NIDA can do and how she tries to maintain the integrity of an agency that claims the scientific high ground while operating in a highly politicized context.I'm fairly sure that Dr. Volkow had never before been pressed on these issues in a public interview. I found her responses frustrating but was grateful for her willingness to have this conversation.Listen to this episode and let me know what you think. Our number is 1-833-779-2460. Our email is psychoactive@protozoa.com. Or tweet at me, @ethannadelmann. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.

More on the first hearing of the House select committee on the Jan 6th Thing. "Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health." She's also the great granddaughter of communist revolutionary Leon Trotsky. That ROCKS! plus many details about the importance of vaccination.

Dr. Cindy Jacobs, PhD, MD, President and Chief Medical Officer at Achieve Life Sciences discusses the grant that was awarded from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) to evaluate the use of cytisinicline as a treatment for the cessation of nicotine e-cigarette use. #AchieveLifeSciences Cindy Jacobs, Ph.D., M.D. · President & Chief Medical Officer, Achieve Life Sciences Inc. Dr. Jacobs is an experienced executive in drug development with expertise in several indications and over 30 years' experience in Biotechnology/Pharmaceutical industry. Dr Jacobs has achieved regulatory success in several product approvals. Prior to joining Achieve Life Sciences in 2017, Dr. Jacobs served as OncoGenex's Executive Vice President and Chief Medical Officer since August 2008, and had been Executive Vice President and Chief Medical Officer of OncoGenex Technologies Inc. from September 2005 to August 2008. From 1999 to July 2005, Dr. Jacobs served as Chief Medical Officer and Senior Vice President, Clinical Development of Corixa Corporation. Prior to 1999, Dr. Jacobs held Vice President, Clinical Research positions at two other biopharmaceutical companies. Dr. Jacobs received her Bachelor's degree in Microbiology from Montana State University, her Master's degree and Ph.D. degree in Veterinary Pathology/Microbiology from Washington State University and an M.D. degree from the University of Washington Medical School. She has in-depth biotechnology experience in preclinical development, pharmacokinetic/drug metabolism studies, toxicology studies, clinical operations, Phase 1-4 trials in a variety of therapeutic areas, regulatory affairs, biostatistics, data management, medical information and quality assurance. Based on her preclinical work at Immunex Corporation, she is one of 2 inventors on the patent for Enbrel.

This episode was a painful realization of the true heartbreak of addiction and mental illness and it still continues to hit home for us. Relapse is a common part of the recovery process. Boredom and isolation could easily be listed as the number one reason for relapse by many individuals in early recovery. Any and all down time prior to recovery was usually used getting their substance, using their substance, and recovering from their substance. According to the National Institute on Drug Abuse (NIDA), relapse statistics show that 40-60% of people relapse after completing treatment. Common triggers for relapse are fear, resentment, boredom, and unrealistic expectations. Stress, exhaustion, loneliness, depression, and anxiety. Revisiting people, places, or things that used to lead to drug use. One thing I have come to understand and accept is that addiction is a lifelong diagnosis that needs constant management and vigilance. Setting healthy boundaries is one of THE BEST ways to love someone struggling with addiction. But most importantly, DON'T GIVE UP. Don't be discouraged. Relapse doesn't mean treatment was unsuccessful or that your loved one won't be able to stay clean in the long run. It can even be helpful in teaching them what certain triggers are and how to avoid them in the future. It's never too late for your loved one; don't give up hope, they need to know they matter to you. If you are in the Portland Oregon or Vancouver, WA area please turn to www.bridgestochange.com who can help you support your loved one. If you are suffering from mental health, addiction and homelessness, they are here specifically to help YOU.

So, remember that episode of The Brady Bunch when Carol Brady found a pack of cigarettes in Greg's jacket pocket and the entire episode revolved around if the parents believed Greg's lie when he stated that they weren't his? I do! I remember it effecting me pretty hard, always thinking, "I would NEVER smoke!" Yet, I was also watching 90210, Degrassi, Criminal Minds, Family Guy and many other shows that depicted a lot worse then smoking. Why and how are we (as the viewing audience) affected and changed by the media we watch, and how does addiction shown in entertainment media change our opinions? Does it change our opinions? This episode I got the opportunity to sit down and talk about this, and much more, with the incredibly funny, smart and positive Even Smith. Not only is he the co-host of Delta Sparks Pod along with @Andie.At.Electrical, but he is also a recovering addict. Even gives us a peak behind the certain and lets us in on a world that I am not enterally familiar with. Through his experiences and history with addiction and recovery, we take a closer look at how addiction and recovery are portrayed, analyzed and discussed in many different entertainment mediums. How is the show, "Mom" showing their AA meetings, and how are they making it recognizable and relatable to others who have gone through it? Why are we not surprised and shocked that Dr. Gregory House is addicted to pain killers while still being employed? Why is it easier to digest animated shows that are portraying addiction such as; American Dad, Archer, The Boondocks? Is it the responsibility of those who are making the shows, movies, music videos, documentaries to educate and inform the viewing audience? When does the line get crossed, when do we we say that it is too much? When will Tabloids and Magazines stop using a relapse as "Breaking News"? Cover Art: @Psych_a_relic Intro Music: @RiRiRetro Find Our Guest Even Smith on Instagram @E.S.Sparks, Podcast: Delta Sparks Pod; Instagram, Twitter, Website and all podcast streaming platforms. Remember to #KeepTalkingFandoms with us on; Instagram, Twitter, and Facebook *Please Note* This episode contains some topics and discussions that might not be suitable for all ages. My guest and I suggest those under the age of 16 to be heavily advised of topics that are discussed in this week's episode. Please note that this episode contains Trigger Warnings that will be placed throughout this episode. Topics include; addiction of many varieties that include but are not limited to; drugs and alcohol, body dysmorphia and addictive behaviors. Along with; suicide, addiction recovery, criminal acts and behaviors. My guest will also be talking about their own experiences and history with addiction and recovery with himself and their family. Please note there will be stronger language than in most other episodes. Addiction Hotlines/Resources: Addiction Guide - Has a large list of beneficial and important websites/links Substance Abuse and Mental Health Services Administration: (samhsa.gov) 1-800-662-4357 (1-800-662- HELP) (24/7 365) The National Institute on Drug Abuse (NIDA) (drugabuse.gov) 301-443-1124 The National Institute of Alcohol Abuse and Alcoholism (NIAAA) (niaaa.nih.gov) 301-443-3860 The National Institute of Mental Health (NIMH) (nimh.nih.gov) 301-443-4513 Center for Substance Abuse Treatment (CSAT) (samhsa.gov) Substance Abuse Treatment Facility Locator (SAMHSA) --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/lets-talk-fandoms/support

What is the aftermath of the COVID pandemic in terms of damage from drugs? What is the science behind helpful or harmful effects of marijuana? What are the strategies in treating methamphetamine use disorder? What is universal prevention in terms of protection from addiction. Learn all this and more from a key national leader, Dr. Wilson Compton. Dr. Wilson Compton Dr. Wilson M. Compton serves as the Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health.  NIDA supports most of the world's research on the health aspects of drug abuse and addiction related to preventing drug abuse, treating addiction and addressing the serious health consequences of drug abuse, including related HIV/AIDS and other health conditions. In his current role, Dr. Compton's responsibilities include working with the Director to provide scientific leadership in the development, implementation, and management of NIDA's research portfolio in order to improve the prevention and treatment of drug abuse and addiction. Prior to his current appointment, Dr. Compton served as the Director of NIDA's Division of Epidemiology, Services and Prevention Research from 2002 until 2013. In this leadership role, he oversaw the scientific direction of a complex public health research program of national and international scope addressing: 1) the extent and spread of drugs of abuse, 2) how to prevent drug abuse, and 3) how to implement drug abuse prevention and treatment services as effectively as possible.  Of note, since 2010 he has led the development of the Population Assessment of Tobacco and Health study (PATH), a large scale longitudinal population study with 45,971 baseline participants ages 12 and older. Jointly sponsored by NIDA and the U.S. Food and Drug Administration (FDA), PATH includes prospective data collection using both surveys and biological assessments to inform the development of tobacco regulations in the United States. Before joining NIDA, Dr. Compton was a tenured faculty member in the Department of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University in Saint Louis, as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis.  Dr. Compton received his undergraduate education from Amherst College. He attended medical school and completed his residency training in psychiatry at Washington University. During his career, Dr. Compton has achieved multiple scientific accomplishments: he was selected to serve as a member of the DSM-5 Revision Task Force; is the author of more than 200 publications including widely-cited papers drawing attention to the opioid crisis in the U.S.; and is an invited speaker at multiple high-impact venues, including multiple presentations to federal judges in presentations sponsored by the Federal Judicial Center.  These judicial presentations have focused on how the science of addiction may improve policy and practices related to persons with addiction within the criminal justice system. Dr. Compton is a member of numerous professional organizations, including the Alpha Omega Alpha medical education honor society. Dr. Compton is also the recipient of multiple awards, including the Senior Scholar Health Services Research Award from the American Psychiatric Association in 2008 and the Paul Hoch Award from the American Psychopathological Association in 2010. The FDA selected him to receive the Leveraging Collaboration A

Natasha Silver Bell is a former model and founder of SilverBell Coaching, a coaching service that provides discreet emotional and behavioral support, through comprehensive strategies, for eating disorders, mental health disorders and substance abuse. Listen to Dr. Allie and Bridget Malcolm in conversation with Natasha Silver Bell as they speak about her experience with Substance Use, Recovery and Coaching. Natasha started modeling at the age of 16 and was signed with Ford Models. She has worked internationally and with brands like Valentino, Hermes, and Etro. Natasha has more than a decade of experience working in the field of addiction and is a member of the International Coaching Federation. Natasha understands firsthand the importance of creating a safe, compassionate, non-judgmental environment in which healing can happen. Her own recovery is what set her on the path to developing SilverBell Coaching and her life in service. She is a single mom residing on the Upper East Side of Manhattan raising her three teenage children. She's an active philanthropist, a yoga and meditation practitioner, and an avid reader. In addition to the transformative work at SilverBell Coaching, Natasha is a co-founder at Due North Quest and recently co-founded Youth Prevention Mentors (YPM). Please note that the contents of Model Mentality are for informational purposes only. The content is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek the advice of your mental health professional or other qualified health provider with any questions you may have regarding your condition. Never disregard professional advice or delay in seeking it because of something you have heard on Model Mentality. As always, if you are in crisis or you think you may have an emergency, call your doctor or 911 immediately. If you're having suicidal thoughts, call 1-800-273-TALK (8255) to talk to a skilled, trained counselor at a crisis center in your area at any time (National Suicide Prevention Lifeline). If you are located outside the United States, call your local emergency line immediately. The views and opinions expressed by guests of the podcast are those of each individual guest and do not reflect the views and opinions of Mind Studios or Dr. Allie Sharma and do not constitute an endorsement of such views and opinions. Thank you for listening to Model Mentality. Model Mentality is brought to you by Mind Studios. Links: SilverBell Coaching: https://silverbellcoaching.com/ References for the 'Let's Get Clinical' segment: National Institute on Drug Abuse (NIDA): https://www.drugabuse.gov/ --- Support this podcast: https://anchor.fm/modelmentality/support

In episode 8, Dr. Ericka Boone joins us for a candid conversation about her journey to "Soul Good".  She shares her experience from grad school to her role as Director of the National Institutes of Health (NIH) Division of Loan Repayment. She vividly describes how she overcame what she discovered was imposter fears as well as her courageous successes.  Prior to this position, Dr. Boone served as a Health Scientist Administrator in the Office of Science Policy and Communications at the National Institute on Drug Abuse (NIDA) where she developed and targeted science-based publications, outreach initiatives, and other activities to educate a variety of audiences about the science of drug use, abuse, and addiction. Ericka is also the owner and lead designer for Live Laugh Bejeweled.  She has an eye for creating the most original accessories for all the Bejeweled Baes out there.  The ethnic-inspired and custom leather accessories are an extension of her mission to be more of her authentic and genuine self.   Listen to this episode as she inspires us to be our best selves.  Website: https://www.livelaughbejeweled.com/  Instagram - @livelaughbejeweled Facebook: @LiveLaughBejeweled  

Alcohol has a long known history of serving the way we celebrate, cope, and socialize across many societies. Some individuals have a rather healthy relationship with it, some are struggling to keep the balance, and some are neutral. Alcohol consumption lowers one's mood and inhibitions, and has three major impacts on one's personal life; these impacts being physiological, relational, and social. Given the current pandemic, many people turn to alcohol for different reasons which we will discuss in this dialogue. People in recovery are struggling, and partners and parents are concerned. They want to know if their loved ones are developing a dependency on alcohol, or if their consumption is just a temporary escape which will pass as the stress of the pandemic lifts. In this dialogue, Paul and I speak about what constitutes an alcoholic drink, and what the appropriate amount of consumption is in relation to our current context. Paul brings his holistic lens as a professor, researcher, practitioner, and a visionary, to debunk the myths that surround alcohol in a compassionate and non-judgmental tone.ResourcesAlcoholics Anonymous (AA)AL-ANANDrinkawareDrink lessWhat you need to know about alcohol and Covid - World Health Organization (WHO)National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA): +1 (800) 662- 4357About Professor Paul WallaceProfessor Paul Wallace FRCGP FFPHM is Clinical Director for Digital at the South London Academic Health Science Network and Professor Emeritus of Primary Care at UCL. His clinical academic career spans more than 30 years. During this time, his research has focussed on the promotion of health by primary care physicians and the use of digital technologies to optimise such activities. He was formerly Director of the NIHR Primary Care Research Network and led an international programme of research into the effectiveness of digitally mediated screening and brief interventions for alcohol in primary care settings. He has authored more than 120 papers and book chapters, and has been involved in the development, evaluation and dissemination of digital applications for alcohol reduction in a number of countries. Paul is past President of the Telemedicine section of the Royal Society of Medicine, past President of the European General Practice Research Network and a founding member of the European Society of General Practice/Family Medicine. He is a Fellow of the Royal College of General Practitioners and the Faculty of Public Health Medicine at the Royal College of Physicians. In 2012 he co-founded the Foundation for Family Medicine in Palestine of which he is the Chief Executive Officer. In 2013 he was awarded the RCGP President's Medal.

Have a quick question about benzo withdrawal? About the symptoms? About the duration of recovery? About anxiety, insomnia, or anything else which is keeping you awake at night? Listen in on our conversation and you just might learn something.In today's episode, we provide a rapid-fire style format where we explore some common questions about benzos, withdrawal, and other related issues. We also have a story from the United Kingdom, explore our barriers to emotion, and touch on one of the more sensitive topics in withdrawal, suicide. Welcome to Episode #34 Today, we take a different tack on our format. We're doing a rapid-fire type of format and answer some questions about benzos, withdrawal, anxiety, insomnia, and other related topics. We also tackle the topic of suicide through the lens of a personal experience last weekend from your host and hear a benzo story from the U.K. But first, let's list the resources used in this episode, and then we'll dive deeper into the content of episode 34. Episode Index Each time listed below is in minutes and seconds. Introduction: 0:57Benzo Story: 12:02Feature: 15:51Moment of Peace: 43:42 Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Benzo Free of the resource or any recommendations or advice provided therein. INTRODUCTIONBENZO FREE: Suicide Prevention Resources. Itzkoff, David. Robin. New York: Macmillan Audio, 2018. https://www.amazon.com/dp/B07BB62KSZ/ref=cm_sw_em_r_mt_dp_U_jqWBDb9P1DN1W. FEATURE: Quick Questions About Anxiety, Insomnia, Benzos, and WithdrawalAshton, C. Heather. Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual). 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.. Foster, D E. Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal. Erie, Colorado: Denim Mountain Press, 2018. http://www.benzofree.org/book.IMS Health. Vector One: National (VONA) and Total Patient Tracker (TPT) Database (2013). Extracted April 2014. Quoted in CCHR International. "Total Number of People Taking Psychiatric Drugs in the United States." Accessed April 3, 2018. https://www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/. National Institute on Drug Abuse (NIDA). "Definition of Tolerance." The Neurobiology of Drug Addiction. Updated January 2007. Accessed August 6, 2017. https://www.drugabuse.gov/publications/teaching-packets/neurobiology-drug-addiction/section-iii-action-heroin-morphine/6-definition-tolerance. Sommers, Jack, "Masculinity Audit into Causes of Suicide Reveals Men Suffer Depression in a Way Even Doctors Could Miss," Huffington Post UK, November 17, 2016, accessed April 26, 2018, https://www.huffingtonpost.co.uk/entry/mens-mental-health-building-modern-men_uk_58206805e4b0c2e24ab022fb. BENZO FREE LINKSWebsitePodcast Home PageFeedback FormDisclaimer Podcast Summary This podcast is dedicated to those who struggle with side effects, dependence, and withdrawal from benzos, a group of drugs from the benzodiazepine and nonbenzodiazepine classes, better known as anti-anxiety drugs, sleeping pills, sedatives, and minor tranquilizers. Their common brand names include Ambien, Ativan, Klonopin, Lunesta, Valium, and Xanax. Introduction In today's intro, we tackle the subject of suicide. I share a story about a book I've been listening to, Robin by David Itzkoff, and about how hearing about his tragic death triggered my emotions this past weekend. I then compared his story with mine and others and reminded people that benzo withdrawal is not a terminal diagnosis, not by a long shot. This illness is temporary, and if you are having suicidal thoughts, to seek help and get support. Benzo Stories Today's benzo story was from Lynn in the United Kingdom. Featured Topic Today's featured topic: Quick Questions About Anxiety, Insomnia, Benzos, and Withdrawal